Vitamins & Minerals - G7

  • G7
  • In 2024, the revenue in the Vitamins & Minerals market market in the G7 countries amounts to a staggering US$8.12bn.
  • This market is projected to experience an annual growth rate of 4.91% between 2024 and 2029 (CAGR 2024-2029).
  • When compared globally, in China leads the pack with the highest revenue generated in the Vitamins & Minerals market market, amounting to US$5,328.00m in 2024.
  • This showcases in China's dominance in this industry.
  • To put things into perspective, in 2024, the per person revenue generated in the Vitamins & Minerals market market is US$10.43.
  • This figure takes into account the total population of the G7 countries.
  • In the United States, the trend in the Vitamins & Minerals market is shifting towards natural and organic supplements, driven by increased consumer awareness about health and wellness.

Key regions: Japan, United Kingdom, Australia, Germany, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Vitamins & Minerals market in G7 countries is experiencing steady growth due to increasing customer preferences for health and wellness products.

Customer preferences:
Customers in G7 countries are becoming more health-conscious and are actively seeking products that can support their overall well-being. Vitamins and minerals are essential nutrients that play a crucial role in maintaining good health, and consumers are increasingly aware of their benefits. As a result, there is a growing demand for vitamins and minerals supplements in G7 countries.

Trends in the market:
One of the key trends in the Vitamins & Minerals market in G7 countries is the rising popularity of natural and organic products. Consumers are becoming more conscious about the ingredients in the products they consume and are opting for natural and organic options. This trend is driving the demand for vitamins and minerals derived from natural sources, such as fruits, vegetables, and herbs. Additionally, there is a growing trend towards personalized nutrition, where consumers are seeking customized vitamins and minerals supplements based on their individual needs and health goals.

Local special circumstances:
Each G7 country has its own unique market dynamics and consumer preferences. For example, in the United States, there is a strong emphasis on preventive healthcare, leading to a high demand for vitamins and minerals supplements. In Japan, there is a strong cultural belief in the benefits of traditional herbal remedies, which has led to a preference for vitamins and minerals derived from natural sources. In Germany, consumers have a preference for organic and sustainable products, driving the demand for natural vitamins and minerals supplements.

Underlying macroeconomic factors:
The growing Vitamins & Minerals market in G7 countries can be attributed to several underlying macroeconomic factors. Firstly, the increasing disposable income levels in these countries have allowed consumers to prioritize their health and wellness needs. With higher incomes, consumers are willing to spend more on vitamins and minerals supplements to support their overall well-being. Secondly, the aging population in G7 countries is driving the demand for vitamins and minerals supplements, as older adults tend to have higher nutritional needs. Lastly, the COVID-19 pandemic has further highlighted the importance of maintaining good health, leading to an increased focus on preventive healthcare and the demand for vitamins and minerals supplements.In conclusion, the Vitamins & Minerals market in G7 countries is experiencing growth due to increasing customer preferences for health and wellness products. The rising popularity of natural and organic products, the trend towards personalized nutrition, and the unique market dynamics in each G7 country are driving the demand for vitamins and minerals supplements. The underlying macroeconomic factors, such as increasing disposable income levels, the aging population, and the impact of the COVID-19 pandemic, are also contributing to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)